Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Beclometasone dipropionate 0.25 mg/g Cream

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Beclometasone dipropionate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Beclometasone dipropionate
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for Beclometasone dipropionate Cream contains a medicine called beclometasone dipropionate. It belongs to a group of medicines called steroids. It helps to reduce swelling and irritation. This medicine is used to help reduce the redness and itchiness of certain skin problems. These skin problems include eczema, psoriasis or dermatitis.

What you need to know before you take it

e Beclometasone dipropionate 0.25 mg/g Cream Do not use Beclometasone dipropionate 0.25 mg/g Cream:

  • if you are allergic to beclometasone dipropionate or any of the other ingredients (listed in section 6)
  • on the eyes
  • on a child under 1 year old
  • to treat any of the following skin problems, it could make them worse:
  • acne
  • severe flushing of skin on and around your nose (rosacea)
  • spotty red rash around your mouth (perioral dermatitis)
  • itching around your back passage or private parts – unless your doctor has told you to do so
  • viral infections, such as cold sores, herpes or chicken pox
  • fungal infections, such as ringworm, athlete's foot or thrush
  • skin blisters or sores that are caused by an infection
  • varicose ulcers (ulcers caused by swollen veins)
  • stasis ulcers (ulcers caused by reduced blood or body fluid flow) If any of the above apply to you, speak to your doctor or pharmacist. Warnings and precautions Talk to your doctor or pharmacist before using Beclometasone dipropionate 0.25 mg/g Cream

127/L/m/8

–

if you are applying the cream under an airtight dressing, including a child's nappy. These dressings make it easier for the active ingredient to pass through the skin. It is possible to accidentally end up using too much cream if you have psoriasis. Your doctor will want to see you more often.

If there is a worsening of your condition during use consult your prescriber – you may be experiencing an allergic reaction, have an infection or your condition requires a different treatment. If you experience a recurrence of your condition shortly after stopping treatment, within 2 weeks, do not restart using the cream without consulting your prescriber unless your prescriber has previously advised you to so. If your condition has resolved and on recurrence the redness extends beyond the initial treatment area and you experience a burning sensation, please seek medical advice before restarting treatment. Contact your doctor if you experience blurred vision or other visual disturbances. Do not smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it. If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine. Other medicines and Beclometasone dipropionate 0.25 mg/g Cream Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines Beclometasone dipropionate 0.25 mg/g Cream is unlikely to affect your ability to operate

machinery or to drive. Beclometasone dipropionate 0.25 mg/g Cream contains chlorocresol and cetostearyl alcohol including cetyl alcohol This medicine contains chlorocresol, which may cause allergic reactions. This medicine also contains cetostearyl alcohol including cetyl alcohol, which may cause local skin reactions (e.g. contact dermatitis). Corticosteroid creams, ointments and other topical preparations come in four different potencies or strengths. These are known as mild, moderately potent, potent or very potent. Healthcare professionals will usually refer to topical corticosteroid potency rather than strength. A potent or strong corticosteroid has a much stronger effect than a mild corticosteroid when using the same amount. The percentage of active ingredient that is sometimes included on product packaging does not indicate potency. Beclometasone dipropionate 0.25 mg/g Cream is classed as a moderate corticosteroid. Your healthcare professional will prescribe or advise a steroid of the appropriate potency for your condition.

How to take it

Beclometasone dipropionate 0.25 mg/g Cream Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

127/L/m/8

Using this medicine

  • You usually apply the cream twice a day. This may be reduced as your skin begins to get better.
  • If your skin problem does not improve after 2 to 4 weeks talk to your doctor.
  • This cream is for use on your skin only.
  • Do not use on large areas of the body for a long time (such as every day for many weeks or months) – unless your doctor tells you to.
  • The germs that cause infections like warm and moist conditions under dressings so always clean the skin before a fresh dressing is put on.
  • If you are applying the cream on someone else make sure you wash your hands after use or wear disposable plastic gloves.
  • Do not mix with any other creams or ointments. Guidance on how to apply the cream 1. Wash your hands. 2. Gently rub the correct amount of cream into the skin until it has all disappeared. You can measure how much cream to use with your fingertip. This picture shows one fingertip unit.

3. Unless you are meant to apply the cream to your hands as a part of the treatment, wash them again after using the cream. For an adult You should find that:

  • two fingertips of cream will cover both hands or one foot
  • three fingertips of cream will cover one arm
  • six fingertips of cream will cover one leg
  • fourteen fingertips of cream will cover the front and back of the body. Do not worry if you find you need a little more or a little less than this. It is only a rough guide.

127/L/m/8

For a child

  • Do not use it on children under 1 year of age.
  • The smaller the child the less you will need to use.
  • A child of 4 years needs about a third of the adult amount.
  • A course of treatment for a child should not normally last more than 5 days – unless your doctor has told you to use it for longer. Your doctor may suggest applying the cream under an airtight dressing. It will only be to help the cream to start working. After a short period of time you will then apply the cream as normal. If you apply Beclometasone dipropionate 0.25 mg/g Cream to your face You should only apply the cream to your face if your doctor tells you to and for not more than 5 days. Do not cover the treated area with a dressing, as the skin on your face thins easily. Do not let the cream get into your eyes. If it does, wash it out with plenty of water. How long You should stop using the cream as soon as the skin problem is better. Sometimes only a few days treatment is needed. If there is no improvement after 2 to 4 weeks, see your doctor again. If the doctor recommends that you continue to use the cream, you should never use it for more than 4 weeks without seeing your doctor again. If your doctor has prescribed the cream for psoriasis you should let your doctor review your progress at regular intervals, as such treatment needs careful supervision. If you use more Beclometasone dipropionate 0.25 mg/g Cream than you should If, by mistake on a few occasions you use more than you should, do not worry. If you apply a lot or if a lot is accidentally swallowed, it could make you ill. 1. Tell your doctor, pharmacist or nearest hospital casualty department immediately. 2. Take the cream tube with you so that people can see what you have used or taken. 3. Do this even if you feel well. If you forget to use Beclometasone dipropionate 0.25 mg/g Cream If you forget to use the cream, use it as soon as you remember, but if it is almost time for your next dose, skip the missed dose and continue as usual. Do not use a double dose to make up for a forgotten dose.

127/L/m/8

If you stop using Beclometasone dipropionate 0.25 mg/g Cream If you use Beclometasone dipropionate Cream regularly make sure you talk to your doctor before you stop using it. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. STOP using Beclometasone dipropionate 0.25 mg/g Cream and tell your doctor as soon as possible if:

  • you find that your skin problem gets worse. You may be allergic to the cream or have a skin infection which needs other treatment. Other side effects you may notice when using Beclometasone dipropionate 0.25 mg/g Cream include:
  • a feeling of burning, irritation or itching where the cream is applied. These may be similar to the skin condition being treated
  • if you have psoriasis you may get raised bumps with pus under the skin. This can happen during or after the treatment and is known as pustular psoriasis
  • blurred vision. Side effects if you use this medicine for a long time, or you use a lot each time you apply it, or you apply it under an airtight dressing or a nappy:
  • stretch marks may develop
  • veins under the surface of your skin may become more noticeable
  • increased hair growth and changes in skin colour
  • thinning of your skin and it damages more easily
  • weight gain, rounding of the face and high blood pressure. These are more likely to happen in infants and children. Steroid withdrawal reaction: If used continuously for prolonged periods a withdrawal reaction may occur on stopping treatment with some or all of the following features: redness of the skin which can extend beyond the initial area treated, a burning or stinging sensation, intense itching, peeling of the skin, oozing open sores. If you absorb or swallow this medicinal product in large quantities, it can make you ill. This is unlikely when you use the cream normally. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

How to store it

Beclometasone dipropionate 0.25 mg/g Cream Keep this medicine out of the sight and reach of children.

127/L/m/8

Do not use this medicine after the expiry date which is stated on the tube and on the carton after EXP. The expiry date refers to the last day of that month. •

Do not store above 25°C. Store in the original package in order to protect from light.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Beclometasone dipropionate 0.25 mg/g Cream contains

  • The active substance is beclometasone dipropionate. Each 1 g contains 0.25 mg of beclometasone (0.025% w/w) as dipropionate
  • The other ingredients are chlorocresol, cetomacrogol 1000, cetostearyl alcohol, white soft paraffin, liquid paraffin, sodium acid phosphate, phosphoric acid, sodium hydroxide and purified water. (See end of section 2 for further information on chlorocresol and cetostearyl alcohol). What Beclometasone dipropionate 0.25 mg/g Cream looks like and contents of the pack Within each carton is an aluminium tube with a plastic screw cap, which contains 15 g, 30 g or 50 g of cream. Not all pack sizes may be marketed. Marketing Authorisation Holder Essential Generics, 8a Crabtree Road, Egham, Surrey TW20 8RN. Manufacturer Purna Pharmaceuticals NV, Rijksweg 17, 2870 Puurs, Belgium. This leaflet was last revised in July 2025.

127/L/m/8

Frequently asked questions about Beclometasone dipropionate 0.25 mg/g Cream

How do I take Beclometasone dipropionate 0.25 mg/g Cream?

Beclometasone dipropionate 0.25 mg/g Cream comes as cream containing 0.25mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Beclometasone dipropionate 0.25 mg/g Cream?

The active substance in Beclometasone dipropionate 0.25 mg/g Cream is beclometasone dipropionate.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Beclometasone dipropionate 0.25 mg/g Cream, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Beclometasone dipropionate 0.25 mg/g Cream without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Beclometasone dipropionate (44 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Beclometasone dipropionate Cream is indicated for the treatment of the various forms of eczema in children and adults including atopic and discoid eczemas; primary irritant and allergic dermatitis; psoriasis (excluding widespread plaque psoriasis); neurodermatoses including lichen simplex; intertrigo; discoid lupus erythematosus.

The cream is often appropriate for moist or weeping surfaces and the ointment for dry, lichenified or scaly lesions but this is not invariably so.

4.2. Posology and method of administration

Posology

Beclometasone dipropionate Cream should be applied thinly over the whole of the affected area and gently rubbed in. Initially, application should be made twice daily, but when improvement is seen, the intervals between applications may be extended and treatment eventually stopped. If no improvement is seen within two to four weeks, reassessment of the diagnosis, or referral may be necessary. After cessation of treatment, should the condition recur, twice daily treatment should be re-instituted. However, when improvement is seen again, the intervals between applications may be gradually extended until maintenance dosing of application every third or fourth day is achieved. This is likely to avoid subsequent reappearance of the condition.

The beneficial effects may be enhanced by preliminary use of hot soaks, or by intermittent applications or occlusive dressings.

Method of administration

For topical administration

4.3. Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

The cream should not be applied to the eyes. Rosacea, acne vulgaris; perioral dermatitis. Primary cutaneous viral infections (e.g. herpex simplex, chickenpox). Hypersensitivity to the preparation. Varicose ulcers or any other stasis ulcers.

Use of Beclometasone dipropionate Cream is not indicated in the treatment of primarily infected skin lesions caused by infection with fungi (e.g. candidiasis, tinea) or bacteria (e.g. impetigo); primary or secondary infections due to yeasts; perianal and genital pruritus; dermatoses in children under 1 year of age, including dermatitis and napkin eruptions.

4.4. Special warnings and precautions for use

Long-term continuous therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur even without occlusion.

The face, more than other areas of the body, may exhibit atrophic changes after prolonged treatment with potent topical corticosteroids. This must be borne in mind when treating such conditions as psoriasis, discoid lupus erythematosus and severe eczema. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye, as glaucoma might result.

If used in childhood, or on the face, courses should be limited if possible to five days and occlusion should not be used.

Topical corticosteroids may be hazardous in psoriasis for a number of reasons including rebound relapses, development of tolerance, risk of generalised pustular psoriasis and development of local or systemic toxicity due to impaired barrier function of the skin. If used in psoriasis careful patient supervision is important.

Long term continuous or inappropriate use of topical steroids can result in the development of rebound flares after stopping treatment (topical steroid withdrawal syndrome). A severe form of rebound flare can develop which takes the form of a dermatitis with intense redness, stinging and burning that can spread beyond the initial treatment area. It is more likely to occur when delicate skin sites such as the face and flexures are treated. Should there be a reoccurrence of the condition within days to weeks after successful treatment a withdrawal reaction should be suspected. Reapplication should be with caution and specialist advise is recommended in these cases or other treatment options should be considered.

Appropriate antimicrobial therapy should be used whenever treating inflammatory lesions which have become infected. Any spread of infection requires withdrawal of topical corticosteroid therapy and systemic administration of antimicrobial agents.

Bacterial infection is encouraged by the warm, moist conditions induced by occlusive dressings, and so the skin should be cleansed before a fresh dressing is applied.

Visual disturbance

Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.

Fire hazard in contact with dressings, clothing and bedding

Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it.

Excipients

This medicine contains chlorocresol and cetostearyil alcohol.

Chlorocresol may cause allergic reactions.

Cetostearyl alcohol may cause local skin reactions (e.g. contact dermatitis).

The label will state moderate steroid.

4.5. Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed.

4.6. Fertility, pregnancy and lactation

Pregnancy

There is inadequate evidence of safety in human pregnancy. Topical administration of corticosteroids to pregnant animals can cause abnormalities of foetal development including cleft palate and intrauterine growth retardation. There may therefore be a very small risk of such effects in the human foetus.

4.7. Effects on ability to drive and use machines

Beclometasone dipropionate 0.25 mg/g cream has no or negligible influence on the ability to drive and use machines

4.8. Undesirable effects

Eye disorders

Not known (cannot be estimated from the available data): Vision, blurred (see also section 4.4).

Skin and Subcutaneous Tissue Disorders

Not known (cannot be estimated from available data): Withdrawal reactions - redness of the skin which may extend to areas beyond the initial affected area, burning or stinging sensation, itch, skin peeling, oozing pustules. (see section 4.4)

Prolonged and intensive treatment with highly active corticosteroid preparations may cause local atrophic changes in the skin such as thinning, striae, and dilatation of the superficial blood vessels, particularly when occlusive dressings are used or when skin folds are involved.

As with other topical corticosteroids, prolonged used of large amounts, or treatment of extensive areas, can result in sufficient systemic absorption to produce the features of hypercorticism. The effect is more likely to occur in infants and children, and if occlusive dressings are used. In infants, the napkin may act as an occlusive dressing.

Should systemic corticosteroid effects arise from application of Beclometasone dipropionate Cream, topical treatment should be discontinued. If adrenal function is impaired the patient will need to be protected from any harmful effects of stress with oral corticosteroid preparations until normal adrenal function is established.

There are reports of pigmentation changes and hypertrichosis with topical steroids.

In rare instances, treatment of psoriasis with corticosteroids (or its withdrawal) is thought to have provoked the pustular form of the disease (see precautions).

Beclometasone dipropionate Cream is usually well tolerated, but if signs of hypersensitivity appear, application should stop immediately. Exacerbation of symptoms may occur.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Should systemic corticosteroid effects arise from application of Beclometasone dipropionate Cream topical treatment should be discontinued. If adrenal function is impaired the patient will need to be protected from any harmful effects of stress with oral corticosteroid preparations until normal adrenal function is established.

🇷🇴 Known in Romania as

Medicines sold in Romania with the same active substance: Cunoscut în România ca

⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.

  • SOPROBEC 50 micrograme pe doza prescriptionBECLOMETASONUM · inhaler / nebuliser
  • SOPROBEC 100 micrograme pe doza prescriptionBECLOMETASONUM · inhaler / nebuliser
  • SOPROBEC 200 micrograme pe doza prescriptionBECLOMETASONUM · inhaler / nebuliser
  • SOPROBEC 250 micrograme pe doza prescriptionBECLOMETASONUM · inhaler / nebuliser
  • RINOCLENIL 100 micrograme/doza prescriptionBECLOMETASONUM · eye / ear / nose
  • CLENIL JET 250 mcg/doza prescriptionBECLOMETASONUM · inhaler / nebuliser

Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

⚠ Not the same combination. This medicine contains Beclometasone dipropionate. The products below do not contain exactly the same set of active substances — they are not direct substitutes.

⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.

  • Formodual partial — not the same combinationBeclometasoni dipropionas + Formoteroli fumaras dihydricus · inhaler / nebuliser
  • Fostex partial — not the same combinationBeclometasoni dipropionas + Formoteroli fumaras dihydricus · inhaler / nebuliser
  • Airiam partial — not the same combinationBeclometasoni dipropionas + Formoteroli fumaras dihydricus · inhaler / nebuliser
  • Beclocomb partial — not the same combinationBeclometasoni dipropionas + Formoteroli fumaras dihydricus · inhaler / nebuliser
  • Befoair partial — not the same combinationBeclometasoni dipropionas + Formoteroli fumaras dihydricus · inhaler / nebuliser
  • Aerox partial — not the same combinationBeclometasoni dipropionas + Formoteroli fumaras dihydricus · inhaler / nebuliser

Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Beclometasone dipropionate 0.25 mg/g Cream. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →